
    
      To evaluate the performance of the recommended strategy for the detection of ANCA based on
      screening with antigen specific immunoassays on a number of AAV patients and relevant disease
      controls (i. e., patients for whom ANCA would be requested in the context of small-vessel
      vasculitis such as patients with infections, drug-induced diseases, connective tissue
      disease, etc.).
    
  